Could a blood extract save sight? early trial tests PRP for rare eye diseases
NCT ID NCT07341919
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This pilot study tests whether injections of platelet-rich plasma (PRP) made from a patient's own blood can help preserve vision in people with retinitis pigmentosa or a related condition called EMAP. Thirty participants receive three injections over four months, and researchers track changes in visual field and visual acuity over six months. The goal is to see if PRP is safe and might slow vision loss.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- platelet-rich plasma (PRP)
- What this could lead to
- If it works, this could point toward a treatment to slow vision loss in certain retinal diseases.
- What could go wrong
- This is a very early, small pilot study with only 30 participants. It may not show clear benefit, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTENSIVE MACULAR ATROPHY WITH PSEUDODRUSEN (EMAP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Especializado Retina e Vítreo
São José do Rio Preto, São Paulo, 15010-100, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an antioxidant pill slow blindness in usher syndrome?
- Eye zap study seeks to prove what patients already feel
- Can an arthritis drug save sight? small trial tests adalimumab for rare eye diseases
- Brain zaps may boost mobility in the visually impaired
- Can a nurse's call ease the shock of an eye disease diagnosis?
- Gene therapy injection aims to slow vision loss in rare eye disease